Navigation path

2002 Projets

Liste des projets 2002 (classés par acronyme)

(description des projets uniquement disponible en anglais)

AFTBVAC Development of a Tuberculosis Vaccine in Africa
AMVTN/AMANET African Malaria Vaccine Testing Network
Bridging gaps Bridging the Gaps Between Public and Traditional Healthcare Sectors – Testing a Model to Improve Quality of STI/HIV/AIDS Care in sub-Saharan Africa
CASA Optimising the Use of the Syndromic Approach for STI Management and Prevention in Resource Poor Settings
CASCADE Virology Virological Characterisation of Primary HIV Infection in the Concerted Action on SeroConversion to AIDS and Death in Europe
China-HIV-VacIII Phase I/II clinical testing of Clade C-based HIV-1 Candidate Vaccines in China
COCONUTKIT Project to coordinate the write up of a protocol for a clinical trial aimed at shortening treatment for tuberculosis
CTL and HIV- super Infection CTL-Mediated Protection from HIV-1 Infection in a High-Risk Cohort in Tanzania: Persistent Seronegativity, Persistent Single-Subtype Infection, and Cross-Subtype Superinfection
EDCTP European and Developing Countries Clinical Trials Programme
EMLI Phase-I and II Trials of the Malaria Pre-Erythrocytic Vaccine LSA-3 and Refinement  of Measurable Outcomes
EMVI European Malaria Vaccine Initiative
EUROMALVAC-2 The Second Phase of a European Malaria Vaccine Development Consortium
EuroVac-III European Vaccine Effort Against HIV/AIDS – III
FACT Development of Oral Fixed Dose Artesunate-Based Combinations for the Treatment of Uncomplicated Malaria
HIVIS Study of Immunogenicity of DNA HIV-1 env, gag and pol Plasmid Vaccines Boosted with MVA in Tanzania: HIV Vaccine Immunogenicity Study
HIVPRIMEBOOST THERVAC Improvement of a Therapeutic Adjuvanted Protein HIV Vaccine by Combination with DNA Immunisation in a Prime-Boost Regimen
LAMNET New Approaches to Improve Coverage and Compliance of Antimalarial Treatment for Pregnant Women in Rural Africa
LONG-DRUG Characterisation of Mycobacterium Tuberculosis Populations During Infection: A  Longitudinal Study on Drug Resistance Development
MALCROSS Genetic Analysis of the Chloroquine Drug Resistance and the Accelerated-Resistance-to Multiple Drugs Phenotypes in the Human Malarial Parasite Plasmodium Falciparum
MALVECASIA Monitoring Insecticide Resistance and Mapping Malaria Vectors in Southeast Asia : A Prerequisite for Sustainable Malaria Vector Control
MAMOP Improving the Management of Childhood Malaria: An Experiment to Bridge the Gap Between Mothers and Healthcare Providers
MICROBICIDES 2002 Conference ‘Microbicides 2002’ Antwerp, 12-15 May 2002
MUVADEN Mucosal Vaccines Against Human and Simian Immunodeficiency Viruses Based on Dendritic Cells
NEW ANTIMALARIALS Clinical and Pre-Clinical Evaluation of Fosmidomycin and its Derivates as Antimalarial Drugs
NEW ANTIMYCOBACTERIALS Inhibitors of the Nonmevalonate Pathway of Isoprenoid Biosynthesis as Drugs Against Tuberculosis
New cAMP antagonists Development of Antagonists that Disrupt the Hyperactivated cAMP Signalling Pathway in Immunodeficiencies as Immunostimulatory Therapy
PERSISTENT TB Novel Drug Targets Specific to Persistent (Latent) Tuberculosis Infection:  Crystallisation, Structure Determination and Functional Studies
SATZ Promoting Sexual and Reproductive Health. School-Based HIV/AIDS Prevention in Sub-Saharan Africa
SPREAD Strategy to Control SPREAD of HIV Drug Resistance
THERAVAC Evaluation of a Therapeutic Vaccination Strategy for HIV-1 Infection TheraVac
Upgrade Diagno MDR-TB Improved Diagnosis, Drug Resistance Detection and Control of Tuberculosis in Latin America
VIRIMAL Structure, Function and Vaccine Potential of the Vir Multigene Family in Malaria
VIRULENCE HIV-1 Reverse Transcriptase Inhibitor Resistance and Its Consequences for Viral Virulence
X-TB Structural and Functional Genomics of Mycobacterium Tuberculosis